Paper41681908
Chemoprevention in Skin Cancer: What Advice?
Ortiz-Brugués A and 9 others. Cancers (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Chemoprevention in Skin Cancer: What Advice? Papers, record 41681908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41681908
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References154
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12502122 | Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis. | Cutis | 2002 | https://conductscience.org/library/papers/12502122 | PubMed |
| 2 | 33318091 | The efficacy and safety of sunscreen use for the prevention of skin cancer. | CMAJ | 2020 | https://conductscience.org/library/papers/33318091 | PubMed |
| 3 | 34063120 | A Skin Cancer Prophylaxis Study in Hairless Mice Using Methylene Blue, Riboflavin, and Methyl Aminolevulinate as Photosensitizing Agents in Photodynamic Therapy. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/34063120 | PubMed |
| 4 | 32484630 | A Randomized Trial of Broad Area ALA-PDT for Field Cancerization Mitigation in High-Risk Patients. | J Drugs Dermatol | 2020 | https://conductscience.org/library/papers/32484630 | PubMed |
| 5 | 16585985 | Topical photodynamic therapy for prevention of new skin lesions in renal transplant recipients. | Acta Derm Venereol | 2006 | https://conductscience.org/library/papers/16585985 | PubMed |
| 6 | 30281145 | Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. | Cancer | 2019 | https://conductscience.org/library/papers/30281145 | PubMed |
| 7 | 31403546 | Use of Topical and Systemic Retinoids in Solid Organ Transplant Recipients: Update and Review of the Current Literature. | Dermatol Surg | 2019 | https://conductscience.org/library/papers/31403546 | PubMed |
| 8 | 25521453 | Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis. | J Invest Dermatol | 2015 | https://conductscience.org/library/papers/25521453 | PubMed |
| 9 | 21709199 | Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21709199 | PubMed |
| 10 | 26488693 | A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention. | N Engl J Med | 2015 | https://conductscience.org/library/papers/26488693 | PubMed |
| 11 | 29246826 | Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes. | J Am Acad Dermatol | 2018 | https://conductscience.org/library/papers/29246826 | PubMed |
| 12 | 21615716 | Photodynamic therapy reduces the histological features of actinic damage and the expression of early oncogenic markers. | Br J Dermatol | 2011 | https://conductscience.org/library/papers/21615716 | PubMed |
| 13 | 39614759 | Evaluating Difluoromethylornithine Safety and Efficacy for Non-Melanoma Skin Cancer Chemoprevention: A Systematic Review. | J Cutan Med Surg | 2025 | https://conductscience.org/library/papers/39614759 | PubMed |
| 14 | 20646334 | Efforts to counteract locally the effects of systemic immunosupression: a review on the use of imiquimod, a topical immunostimulator in organ transplant recipients. | Int J Immunopathol Pharmacol | 2010 | https://conductscience.org/library/papers/20646334 | PubMed |
| 15 | 31394005 | Photodynamic therapy for the prevention and treatment of actinic keratosis/squamous cell carcinoma in solid organ transplant recipients: a systematic review and meta-analysis. | J Eur Acad Dermatol Venereol | 2020 | https://conductscience.org/library/papers/31394005 | PubMed |
| 16 | 31779194 | Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31779194 | PubMed |
| 17 | 34793935 | Topical carvedilol delivery prevents UV-induced skin cancer with negligible systemic absorption. | Int J Pharm | 2022 | https://conductscience.org/library/papers/34793935 | PubMed |
| 18 | 31991834 | The β-Blocker Carvedilol Prevented Ultraviolet-Mediated Damage of Murine Epidermal Cells and 3D Human Reconstructed Skin. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/31991834 | PubMed |
| 19 | 33619293 | The incidence and clinical analysis of non-melanoma skin cancer. | Sci Rep | 2021 | https://conductscience.org/library/papers/33619293 | PubMed |
| 20 | 28796885 | Photodynamic therapy is more effective than imiquimod for actinic keratosis in organ transplant recipients: a randomized intraindividual controlled trial. | Br J Dermatol | 2018 | https://conductscience.org/library/papers/28796885 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41681908
GET https://conductscience.org/api/papers/v1/41681908/references?page=2